Targeted News Service

UT-MD Anderson Cancer Center: ASCO - Novel Targeted Cancer Therapies Demonstrate Activity and Safety in Metastatic Solid Tumors
June 03, 2024

HOUSTON, Texas, June 3 (TNSres) -- The University of Texas's MD Anderson Cancer Center issued the following news release:

* * *

MD Anderson researchers share preliminary clinical data of an antibody-drug conjugate for metastatic colorectal cancer and a USP1 inhibitor for advanced solid tumors

* * *

ABSTRACTS: 3000 (https://meetings.asco.org/abstracts-presentations/231480) and 3005 (https://meetings.asco.org/abstracts-presentations/231487)
. . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your Affiliation	Government Newspaper / Media Business Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions or comments:

Click here for more information about our products

Existing Customer Login

Targeted News Service Document Request Form